VR MED

ICO Ended
377 days 15 hours ago

Description

VR MED is the first medical device in the world to employ VR technology for a wide range of uses. It has similar success not only in ophthalmology, but also neurology and rehabilitation. All you need for the transformation is to put in the required software and configure the system.This equipment covers a large part of the clinic’s needs with VR technology.Today, the VR headset is capable of replacing 40% of all instrument functionality ophthalmology room, having a cost of 6 times less than the cost equipment "Golden Standard". Development of new directions of diagnostics and treatment of patients is conducted.The technology is patented. VRMD tokens will become an internal currency of the platform, allowing users to get software to extend the functionality of the gadget and support new developments on the platform.

General
ICO Dates
07 Jun 2018 - 05 Jul 2018
Whitelist / KYC
Country
UK
Ticket
VRMD
Token Type
ERC20
Financial
ICO price
1 VRMD = 0.25 USD
Accepting
BTC, ETH, LTC, Fiat
Hard Cap
5M $
Tokens for sale
2,000,000
Bonuses
early investors Up to 25%

  • 1
    06.2016

    Start of the development of the VR headset and programming suitable for medical use.

  • 2
    12.16 - 02.17

    Patent granted in Russia. Start of process to receive international patents.

  • 3
    02.17 - 04.17

    Creation of pilot model of equipment and software for screening for early detection of glaucoma and other conditions with peripheral vision defects.

  • 4
    04.17

    Participation at international presentations in Lisbon and Bahrain. Introduction of the device.

  • 5
    05.17-07.17

    Successful approval process for the device and software at the FH Aachen University of Applied Sciences.

  • 6
    07.17-10.17

    Development of the Alpha version of the device, with the capability of providing solutions in ophthalmology (measurement of peripheral vision, diagnosis of glaucoma markers).

  • 7
    03.18 - 06.18

    Development of the device final version (technical and usage fine-tuning), construct improvements.

  • 8
    06.18 - 08.18

    Standard ISO 12866-2011. Industrial design development.

  • 9
    08.18 - 12.18

    Certification of software “Perimeter”: Creation of a universal design for diagnosis of a range of visual functions (through early diagnosis of glaucoma and other peripheral vision field defects).

  • 10
    04.18 - 09.18

    Entrance to the world market: Undergo approval process in India and China clinics; obtain international ISO certification.

  • 11
    05.18 - 07.19

    Upload of users’ data to the platform. Distribution of the device in the European Union, Russia and Asia; Launch of decentralized platform; The 100% functional Perimeter becomes the “gold standard” in ophthalmic diagnosis.

  • 12
    05.18 - 07.19

    Widening of device functionality to include usage in neurology and rehabilitation.